australia's next csl?, page-6

With regards to the following comments ASH81,

- "Expectations are for >50% complete healing rate."

- "The recent TIS Prospectus page 3 refers to the healing rate of 25-50% following up to 20 weeks of treatment. The patients in the first trial were particularly difficult candidates, and it is reasonable to target a >50% healing rate using a normal population and allowing for longer healing periods."

The first appears to be pure speculation on your part and the second follow-up post is actually a misquotation of the company's prospectus.

On page 3 of the recent prospectus when the company refers to the "25 - 50%" healing rate they are in fact referring to the success rate of current treatments available on the market (i.e. compression bandaging) after 20 weeks of treatment (as confirmed in previous studies). This can be confirmed by looking at the sources provided. They are NOT referring to Vitrogro.

The prospectus (page 3) and clinical study results actually state that only 10 of the 30 patients partaking were completely healed over a total of 6 weeks. Therefore clinical results to date suggest a 33% healing rate (if you exclude partial heals), although this is for the most difficult cases of diabetic ulcer. The effect of Vitrogro treatment on more 'normal' cases or with >6 weeks treatment time remains to be seen.